Cardan Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $2.68M | Sell |
20,543
-239
| -1% | -$31.1K | 0.3% | 86 |
|
|
2021
Q2 | $3.69M | Sell |
20,782
-310
| -1% | -$55.1K | 0.41% | 78 |
|
|
2021
Q1 | $3.47M | Buy |
21,092
+432
| +2% | +$71K | 0.42% | 76 |
|
|
2020
Q4 | $3.41M | Sell |
20,660
-31
| -0.1% | -$5.12K | 0.42% | 74 |
|
|
2020
Q3 | $2.95M | Buy |
20,691
+933
| +5% | +$133K | 0.39% | 87 |
|
|
2020
Q2 | $2.18M | Buy |
19,758
+132
| +0.7% | +$14.6K | 0.31% | 99 |
|
|
2020
Q1 | $1.96M | Sell |
19,626
-485
| -2% | -$48.4K | 0.33% | 80 |
|
|
2019
Q4 | $3M | Buy |
20,111
+297
| +1% | +$44.3K | 0.4% | 68 |
|
|
2019
Q3 | $2.54M | Buy |
19,814
+961
| +5% | +$123K | 0.36% | 69 |
|
|
2019
Q2 | $2.69M | Buy |
18,853
+683
| +4% | +$97.4K | 0.41% | 68 |
|
|
2019
Q1 | $2.6M | Sell |
18,170
-81
| -0.4% | -$11.6K | 0.42% | 65 |
|
|
2018
Q4 | $2.26M | Buy |
18,251
+258
| +1% | +$32K | 0.4% | 65 |
|
|
2018
Q3 | $3.03M | Sell |
17,993
-49
| -0.3% | -$8.24K | 0.47% | 59 |
|
|
2018
Q2 | $3.11M | Buy |
18,042
+142
| +0.8% | +$24.5K | 0.51% | 55 |
|
|
2018
Q1 | $2.7M | Buy |
17,900
+241
| +1% | +$36.4K | 0.45% | 58 |
|
|
2017
Q4 | $2.38M | Sell |
17,659
-1
| -0% | -$135 | 0.45% | 61 |
|
|
2017
Q3 | $2.58M | Buy |
17,660
+242
| +1% | +$35.4K | 0.52% | 58 |
|
|
2017
Q2 | $2.71M | Sell |
17,418
-522
| -3% | -$81.2K | 0.53% | 57 |
|
|
2017
Q1 | $2.6M | Sell |
17,940
-219
| -1% | -$31.8K | 0.54% | 59 |
|
|
2016
Q4 | $1.98M | Sell |
18,159
-17
| -0.1% | -$1.85K | 0.44% | 65 |
|
|
2016
Q3 | $2.21M | Buy |
18,176
+102
| +0.6% | +$12.4K | 0.49% | 59 |
|
|
2016
Q2 | $2.55M | Sell |
18,074
-335
| -2% | -$47.3K | 0.63% | 51 |
|
|
2016
Q1 | $2.4M | Buy |
18,409
+6,566
| +55% | +$857K | 0.6% | 53 |
|
|
2015
Q4 | $1.67M | Buy |
+11,843
| New | +$1.67M | 0.71% | 51 |
|